Types of Healthcare Fraud in the USA: Schemes, Warning Signs and Reporting

Healthcare fraud in the United States takes several forms: false billing, fabricated medical need, referral kickbacks, stolen identities, prescription schemes, and manipulation of insurance payments. It can involve providers, suppliers, brokers, patients who knowingly participate, or health plans. An unexpected claim is a reason to investigate; it does not, by itself, prove a crime. The FBI’s healthcare-fraud overview describes schemes affecting both public and private insurance.

Confidence: High for the existence and basic mechanisms of the categories below, which are documented in federal guidance and legal sources. This article does not estimate their national frequency, rank the most common schemes, or determine whether a particular person or organization has committed fraud.

By Pure City Research · Sources checked 12 October 2026 · United States scope. Educational information; individual legal questions require qualified advice. No external legal review is claimed.

Key takeaways

• False claims can concern care that never happened, the price or code for care that did happen, or a false account of eligibility.
• Paid referrals and stolen insurance identities can sit behind otherwise ordinary-looking claims.
• Home health, hospice, telehealth and genetic testing are legitimate services. Their misuse does not make the entire service fraudulent.
• Fraud, abuse, waste and payment errors have different meanings. An improper-payment rate is not a fraud rate.
• Preserve the records, ask for an explanation, and use the reporting route for the affected program.

Contents

• Fraud versus errors, waste and abuse
• Thirteen practical types of healthcare fraud
• Important distinctions in real cases
• How the money moves
• The legal framework
• Warning signs and first steps
• Where to report suspected fraud
• Funding and source credibility
• Frequently asked questions
• Research method and limits

Fraud versus errors, waste and abuse

In everyday language, fraud involves deliberate deception to obtain a payment or benefit. Federal criminal healthcare fraud under 18 U.S.C. §1347 concerns knowingly and willfully carrying out, or attempting, a deceptive scheme involving a healthcare benefit program. Other laws use different liability standards, discussed below.

The Government Accountability Office (GAO) distinguishes fraud from improper payments, waste and abuse. Improper payments include payments that should not have occurred or were made in an incorrect amount. They can result from administrative mistakes or documentation problems. Waste concerns careless or unnecessary spending; abuse concerns improper conduct or misuse of authority. These labels can overlap, but they are not interchangeable.

A large bill, denied claim, unhappy patient, or missing document does not automatically establish fraud. CMS expressly cautions that its improper-payment measurements are not fraud measurements. Likewise, alleged billing amounts, actual losses, recoveries and convictions describe different things. This article does not convert any of them into a national fraud estimate.

Thirteen practical types of healthcare fraud

These are overlapping ways to understand schemes, rather than a statutory list or a prevalence ranking. Illustrations are hypothetical. The conduct, knowledge, applicable billing rules and supporting evidence matter.

On small screens, swipe the table sideways to read every column.

Important distinctions in real cases

Real care can still be part of a false claim

A service may have occurred while its claimed complexity, clinical justification or reimbursement conditions were falsely represented. Conversely, a coding disagreement can be an error or a good-faith dispute. CMS’s April 2026 fraud-and-abuse booklet emphasizes facts, circumstances, intent and knowledge when distinguishing conduct.

Kickbacks and self-referral are separate legal questions

The federal Anti-Kickback Statute can apply even where the patient received medically necessary care. Its safe harbors protect specified arrangements meeting their requirements; a commercial relationship alone does not establish an illegal kickback. OIG explains the rules.

The Stark physician self-referral law separately restricts referrals for designated health services payable by Medicare when a physician or immediate family member has a financial relationship with the entity, unless an exception applies. It uses a strict-liability framework. A prohibited referral therefore should not automatically be described as intentional criminal fraud.

“Free” testing and remote care need context

OIG’s genetic-testing alert describes unsolicited cheek-swab offers used to collect Medicare information and bill unnecessary tests. Legitimate genetic testing can be valuable; the concern is the ordering and payment scheme.

Similarly, OIG distinguishes telefraud from legitimate telehealth. A remote consultation or shipped device is not proof of fraud. Relevant concerns include inappropriate orders, false need and compensation tied to generating business.

Home health and hospice have nuanced eligibility rules

The 1995 home-health alert is used here to document historical scheme mechanisms, not current benefit policy. Under current Medicare home-health guidance, permitted medical trips and short, infrequent absences can coexist with homebound status. Seeing someone outside their home is insufficient to decide eligibility.

Medicare hospice guidance permits care beyond six months when eligibility is recertified. Living longer than an initial prognosis does not establish fraud. Hospice elections affect how terminal-illness-related care is covered, while unrelated covered conditions can still receive Medicare coverage. If enrollment is unexpected, contact Medicare and the provider promptly.

Patients can be victims, witnesses or knowing participants

A stolen identity does not make the patient an accomplice. FTC guidance explains that another person’s medical information may become mixed into the victim’s records, affecting care as well as finances. Multiple legitimate prescribers or a change of doctor likewise do not, on their own, establish prescription fraud.

A settlement is not a criminal conviction

The linked DOJ pharmacy and risk-adjustment notices illustrate alleged payment mechanisms and civil resolutions. Their existence does not convert all allegations into criminal findings. In any named case, distinguish an investigation, charge, settlement, admission, verdict and appeal; each supports a different statement.

How the money moves

Fraud seeks a financial or coverage benefit by distorting information or transactions. This conceptual diagram shows where a scheme can intercept ordinary payment relationships. It identifies no particular business or owner as fraudulent.

There is no single company, parent or investor behind “healthcare fraud.” Ownership and backers must be traced for an identified entity and case. Fees, ownership interests and referral compensation create incentives worth scrutinizing; they are not themselves proof of misconduct. The same discipline applies to payer and enforcement sources.

The legal framework

• Criminal healthcare fraud: 18 U.S.C. §1347 addresses knowing and willful schemes. Actual knowledge of that statute, or specific intent to violate that particular section, is not required.
• Civil False Claims Act: Knowledge includes actual knowledge, deliberate ignorance and reckless disregard; specific intent to defraud is not required. This differs from both an innocent mistake and the criminal standard. CMS guidance
• Anti-Kickback Statute: Covers knowing and willful remuneration to induce or reward federally reimbursable business. Both payment and receipt may be relevant. OIG guidance
• Stark, exclusions and civil penalties: Separate rules can lead to repayment, penalties or exclusion without a criminal healthcare-fraud conviction. State laws and private-insurance rules also matter. CMS; OIG

This is an overview, not a complete legal checklist. Penalty amounts change, and case-specific liability cannot be decided from a consumer warning sign.

Warning signs and first steps

Review the dates, services, providers and quantities in your Explanation of Benefits or Medicare Summary Notice. Follow up on unfamiliar visits, unexplained supplies or enrollment changes. Ask the provider and insurer to explain the claim using contact details you independently verify. CMS reporting guidance provides the relevant program routes.

Be cautious about pressure to hand over coverage information for unsolicited tests, equipment or benefits. Confirm what you are agreeing to and who ordered it. For insurance offers, request written coverage details and check the seller with your state insurance regulator; a medical discount plan is not health insurance. FTC insurance-scam guidance

If identity theft is suspected, obtain and review affected medical records, request corrections in writing, and follow the recovery steps at IdentityTheft.gov. Preserve original correspondence and claim records. Do not publish medical records, insurance identifiers or accusations in a public comment. FTC recovery guidance

Where to report suspected fraud

Report the observed facts and label uncertainty clearly. A report requests investigation; it does not establish guilt. Routes below were checked on 12 October 2026.

For staff considering a whistleblower disclosure, protections depend on the employment category, disclosure and recipient. Seek case-specific guidance; anonymity and protection against retaliation are different questions. HHS-OIG whistleblower information

Funding and source credibility

All substantive evidence here comes from U.S. public bodies and official legal material. That fits the country and legal scope, but concentrates the article in one national and institutional perspective. No commercial sponsor of the particular government guidance was identified in the materials checked; that is not an audit of every contract, donor or employee relationship.

How to read the scorecard: Tiers and A–D grades are editorial judgments about conflicts and fitness for the stated role, not measured accuracy scores. Tier 1 indicates no identified subject-specific financial stake after the checks described. Tier 2 flags indirect institutional interests; here, public payer, enforcement or consumer-protection incentives. Tier 3 denotes an interested party; Tier 4 denotes a source describing its own interests. An A grade here applies to statutory text or oversight definitions; B means useful, with bias and role limits to watch. Public funding does not guarantee impartiality.

On small screens, swipe the scorecard sideways to read every column.

The documented institutional backers are the U.S. government and its public funding mechanisms, with DOJ or HHS as parent departments where applicable. Specific guidance-production budgets, all commercial contracting relationships, and a complete publisher ownership record were not traced. No percentages or undocumented control relationships are asserted.

Frequently asked questions

Is every billing mistake healthcare fraud?

No. Errors and intentional deception need different descriptions. Civil false-claim rules can also reach deliberate ignorance or reckless disregard. The applicable law and evidence determine the result. CMS legal overview

Can insurers or plans be involved?

Yes. Risk-adjustment manipulation targets payment to a health plan, rather than just the code for an individual visit. An unsupported diagnosis warrants validation; intentional fraud requires more than the mere existence of a record error. CMS validation explanation

Which type is most common?

The reviewed sources do not establish a comparable national ranking. Counts of complaints, prosecutions and audits reflect different populations and detection methods.

Should I stop medically necessary treatment because I suspect a claim is wrong?

Discuss care with your treating clinician while separately seeking a billing explanation and reporting concerns. A disputed claim cannot determine whether treatment is clinically appropriate.

Research method and limits

This is a targeted explanatory review of primary federal sources, not a systematic prevalence study or an investigation of a named provider. We checked claim-relevant official guidance, the April 2026 CMS booklet, reporting pages, statutory material and institutional funding disclosures. Sources are linked beside the statements they support; the scorecard groups documents by issuing institution and discloses its funding and role.

Confidence is high for the documented mechanisms and basic distinctions. Population frequency, undetected losses and case-specific culpability remain outside this review. The historical OIG home-health and billing documents support mechanisms, with current Medicare pages used for coverage qualifications. Budget requests describe proposed financing and must not be mistaken for final appropriations. This article contains no prevalence chart because it supplies no comparable quantitative prevalence claim.

For the publication’s general research approach, see Evidence Methods and Editorial Policy. Source-check date: 12 October 2026; this is not a claim of clinician or lawyer review.